Blau Farmacêutica S.A. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was BRL 362.65 million compared to BRL 361.63 million a year ago. Net income was BRL 99.4 million compared to BRL 94.53 million a year ago. Basic earnings per share from continuing operations was BRL 0.56 compared to BRL 0.42 a year ago. Diluted earnings per share from continuing operations was BRL 0.56 compared to BRL 0.42 a year ago.
For the nine months, sales was BRL 985.16 million compared to BRL 1,040.21 million a year ago. Net income was BRL 222.13 million compared to BRL 268.39 million a year ago. Basic earnings per share from continuing operations was BRL 1.2502 compared to BRL 1.51 a year ago. Diluted earnings per share from continuing operations was BRL 1.2502 compared to BRL 1.51 a year ago.